|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenues | ||||
| Product sales | ||||
| Other revenues | ||||
| Total revenues | ||||
| Expenses | ||||
| Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues | ||||
| Product sales | ||||
| Other revenues | ||||
| Selling, general and administrative (Note 3) | ||||
| Research and development | ||||
| Amortization of intangible assets | ||||
| Other expense, net | ||||
| Total expenses | ||||
| Operating income | ||||
| Interest income | ||||
| Interest expense | ||||
| Loss on extinguishment of debt | ||||
| Foreign exchange and other | ||||
| Loss before provision for income taxes | ||||
| Provision for income taxes | ||||
| Net loss | ||||
| Net income attributable to noncontrolling interest | ||||
| Net loss attributable to Bausch + Lomb Corporation | ||||
| Basic loss per share attributable to Bausch + Lomb Corporation (in usd per share) | ||||
| Diluted loss per share attributable to Bausch + Lomb Corporation (in usd per share) | ||||
| Basic weighted-average common shares (in shares) | ||||
| Diluted weighted-average common shares (in shares) |
Loading...